Regulatory News In Brief
This article was originally published in The Tan Sheet
Executive Summary
FTC/Garden of Life case continues; FDA deems ForMor in violation of GMPs; Kanebo faulted for pharmaceutical GMP failures; CytoSport settles litigation over Muscle Milk labeling; USPlabs’ carb claim canned in NAD review; FDA extends comment time on FSMA tracking pilots.
You may also be interested in...
In Brief
CDER clarifies toll-free number labeling; FTC consent decree edit fails in Garden of Life case; NAD rules on Ranir’s Abridge ad; POM Wonderful, FTC plot appeals of ALJ decision; more news In Brief.
In Brief
Nestle takes stake in constipation cure firm
HIV/AIDS, Cancer Cure Supplement Claims Targeted In Six FTC Actions
Western Dietary Products will preliminarily halt Internet marketing claims that its black walnut, wormwood and clove tinctures treat and cure diseases such as cancer, diabetes and HIV/AIDS, the Federal Trade Commission says.